Background: Indonesia has a high number of COVID-19 cases and mortalities relative to not only among the Asia Pacific region but the world. Children were thought to be less affected by the virus compared to adults. Most of the public data reported combined data between adults and children. The Indonesian Pediatric Society (IPS) was involved in the COVID-19 response, especially in the area of child health. One of IPS's activities is collecting data registries from each of their chapters to provide a better understanding of COVID-19 in children.Objective: The objective of this study was to share the data of suspected and confirmed COVID-19 cases in children from IPS's COVID-19 data registry.Method: This is a retrospective study from the IPS's COVID-19 registry data. We collected the data of COVID-19 in children during March to December 2020 from each of the IPS chapters. We analyzed the prevalence, case fatality rate (CFR), age groups, diagnosis, and comorbidities of the children diagnosed with COVID-19.Result: As of December 21, 2020, there were 35,506 suspected cases of children with COVID-19. In total, there were 522 deaths, with a case fatality ratio (CFR) of 1.4. There were 37,706 confirmed cases with 175 fatalities (CFR 0.46). The highest mortality in confirmed COVID-19 cases was from children ages 10–18 years (42 out of 159 cases: 26%). The most common comorbidity and diagnosis found were malignancy (17.3%) and respiratory failure (54.5%).Conclusion: The CFR of confirmed COVID-19 cases in children in Indonesia is high and should be a major public concern.
In the published article, the text in the first paragraph, Methods section showed an incomplete information on the intention of the original data collection and incomplete information on the information comparing the original data with Ministry of Health (MOH) COVID-19 data collection.
Saat ini penutupan duktus arteriosus persisten (DAP) transkateter merupakan terapi pilihan karena memiliki efikasi yang baik, masa rawat yang singkat, risiko yang lebih rendah, dan bebas dari parut dada. Tujuan penelitian ini adalah mengevaluasi luaran jangka pendek dan menengah penutupan DAP transkateter. Penelitian merupakan laporan deskriptif analitik pasien yang menjalani penutupan DAP transkateter secara konsekutif di RS Dr. Hasan Sadikin Bandung selama periode Mei 2011 sampai dengan Juni 2014 dengan melakukan evaluasi pemeriksaan klinis dan ekokardiografi saat 24 jam, 1, 3, 6, dan 12 bulan setelah prosedur. Selama periode penelitian terdapat 132 pasien DAP yang menjalani penutupan transkateter, terdiri atas 42 laki-laki dan 90 perempuan, dengan median usia 3,9 tahun, berat badan 11,25 kg, tekanan sistol arteri pulmonalis 56 mmHg, ukuran defek 3,4 mm, flow ratio 2,8, fluoroscopy time 16 menit, dan procedure time 67 menit. Segera setelah prosedur 54% memperlihatkan penutupan lengkap, smoky residual 41%, dan residual ringan 6%. Sebagian besar pasien dipulangkan sehari setelah prosedur, tidak ada yang meninggal dan komplikasi hanya 3,8%. Semua pasien memperlihatkan penutupan lengkap pada follow-up. Penutupan DAP transkateter merupakan terapi yang aman dan efektif dengan masa rawat yang singkat dan komplikasi yang minimal. Evaluation was conducted through clinical examination and echocardiography 24 hours, 1, 3, 6 and 12 months after the procedure. The procedure was successful in 132 PDA patients (42 males and 90 females). The median age, body weight, systolic pulmonary artery pressure, PDA size, flow ratio, fluoroscopy time, and procedure time were 3.9 years, 11.25 kg, 56 mmHg, 3.4 mm, 2.8, 16 minutes, and 67 minutes, respectively. Immediately after the procedure, 54% patients had complete closure, 41% experienced smoky residual shunt and only 5% experienced small residual shunt. The mortality and complication rate was 3.8%. Most of the patients were discharged the next day after the procedure. All patients showed complete closure during followed-up. Transcatheter closure of PDA is safe and effective with shorter hospitalization and minimum complications. [MKB. 2016;48(4):234-40]
Background: Undernutrition is common in children with congenital heart disease (CHD), especially in developing countries including Indonesia. The objective of the study was to describe the nutritional status of children patients with Tetralogy of Fallot. Methods: This was a cross-sectional descriptive study using 41 medical records of children aged 0-14 years old with Tetralogy of Fallot that visited pediatric outpatient department of Dr. Hasan Sadikin General Hospital in period of January to December 2013. The variable was anthropometric measurement, namely weight-forage , height-forage , weight-for-height, and body mass index-forage. These anthropometric data were analyzed using statistics software, WHO Anthro, and WHO AnthroPlus and were classified based on nutritional status according to WHO. The collected data were displayed in percentage. Results: There were more boys (60.98%) who had Tetralogy of Fallot compared to girls (39.02%). The percentage of undernutrition was 39.02% with 43.75% in 5-14 year old children. The percentage of stunting was 70.73% with 72% in 0-5 year old children. Meanwhile, the percentage of underweight was 52% in children aged 0-5 years old. Conclusions: The percentage of undernourished children with Tetralogy of Fallot is quiet high. Undernutrition occurs more often in 5-14 year old children, while stunting occurs more often in 0-5 year old children.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.